Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders
- PMID: 30275975
- PMCID: PMC6145925
- DOI: 10.1038/s41525-018-0066-3
Heterogeneity in clinical sequencing tests marketed for autism spectrum disorders
Conflict of interest statement
S.W.S. and SickKids Hospital has licensed intellectual property for genetic testing in autism to Athena Diagnostics, Lineagen, Population Bio. S.W.S. is also on the Scientific Advisory Committees of Population Bio and Deep Genomics, and directs the Autism Speaks MSSNG Open Science project. The remaining authors declare no competing interests.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn (American Psychiatric Publishing, Arlington, VA, 2013).
-
- Tammimies, K. et al. Molecular diagnostic yield of chromosomal microarray analysis and whole-exome sequencing in children with autism spectrum disorder. JAMA 1, 314, 895–903 (2015). - PubMed
LinkOut - more resources
Full Text Sources